GE HealthCare has announced an expansion of its radiation oncology portfolio, introducing the AI-enabled MR Contour DL at the ESTRO 2025 Congress in Vienna, Austria.
The new solutions aim to empower healthcare professionals with advanced tools to deliver more precise care, improve efficiency, and enhance patient outcomes in radiation therapy.
GE HealthCare will also showcase its updated Intelligent Radiation Therapy (iRT) software, designed to standardise complex workflows.
The software aims to shorten the timeline from diagnosis to treatment, enabling more precise radiation therapy.
GE HealthCare president and CEO Kelly Londy said: “We’re committed to advancing MR imaging capabilities in radiation therapy to deliver more accurate and precise care.
“The anticipated addition of Spectronic’s software offering to our portfolio would support our vision for an MR-based radiation oncology workflow and would help enable high-precision treatment planning for radiotherapy patients across the globe.”
GE HealthCare plans to integrate Spectronic Medical’s software into its portfolio.
Based in Helsingborg, Sweden, Spectronic Medical specialises in advanced image analysis solutions that improve clinical workflows and patient care in radiation oncology.
The integration aims to enhance GE HealthCare’s magnetic resonance (MR) in radiation therapy expertise.
Spectronic Medical’s MRI Planner software, which has received FDA 510(k) clearance and CE marking, will be leveraged to enable MR-only radiotherapy workflows.
The software uses AI to convert standard MR images into synthetic CT images, crucial for radiation treatment planning, thus enhancing treatment planning capabilities.
The integration of Spectronic Medical technology is expected to complement GE HealthCare’s existing solutions for efficient MR-guided radiotherapy workflows.
These include the AIR RT Coil Suite and AI-based applications like AIR Recon DL and MR Contour DL, which improve image quality and organ segmentation.
Spectronic Medical CEO Carl Siversson said: “Spectronic Medical was founded on the vision that advanced MRI and AI technologies can unlock entirely new possibilities in radiotherapy.
“Our MRI-only radiotherapy planning innovations, amplified by GE HealthCare’s global reach and clinical depth, aim to support the evolution toward more precise, personalised, and accessible cancer care.”
GE HealthCare has also announced the US FDA 510(k) clearance of MR Contour DL, an AI model using deep learning for organs at risk (OAR) segmentation.
The model enhances accuracy by leveraging MR images to create precise organ contours, reducing the manual workload involved in radiation therapy treatment planning.
MR Contour DL can segment 37 organs and structures in the head-neck and pelvic regions using standard 2D or 3D MR image datasets.
It will be integrated into GE HealthCare’s iRT digital solution for radiation therapy workflow management, aiming to reduce diagnostic time and workload.
When combined with the MRI Planner, AIR RT Coil Suite, and AIR Recon DL, MR Contour DL facilitates a complete AI-powered, MR-only simulation workflow.
The integration aims to deliver more precise radiation therapy treatment, showcasing GE HealthCare’s commitment to innovation in patient care.
GE HealthCare oncology general manager Ben Newton said: “Cancer cases are expected to continue to rise, but the silver lining is that survival rates for various cancers have been increasing due to advancements in medical technologies, early detection and improved treatment protocols.
“GE HealthCare is at the forefront of the battle against cancer and the expansion of our radiation oncology portfolio as well as the new AI-enabled innovations highlighted at ESTRO this year are a testament to the investments and efforts we are making to continue the key upward trend of survival following a cancer diagnosis.”
